在血清素受体的功能选择性的结构特征
Daniel Wacker1, Chong Wang, Vsevolod Katritch
1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
概括
素酸二甲基胺和相关化合物在5-HT2B受体上显示偏差信号,激活β-arrestin通路. 结构研究揭示了G蛋白结合受体 (GPCRs) 中这种功能选择性的基础.
科学领域:
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
- 生物化学 生物化学
背景情况:
- G蛋白结合受体 (GPCRs) 通过多种信号通路调解细胞反应.
- 功能选择性,或偏向信号,允许药物调节特定的途径,影响治疗结果.
- 了解GPCR对于开发向疗法和预测药物效应至关重要.
研究的目的:
- 为了研究ergoline化合物在血清素受体上的功能选择性.
- 阐明5-HT2B受体中偏差信号的基础结构机制.
- 为了比较5-HT2B和5-HT1B受体的信号配置.
主要方法:
- 生物化学测试被用来评估药物活性在GPCRs.
- 确定了与厄戈他胺 (ERG) 结合的人类5-HT2B受体的晶体结构.
- 与5-HT1B/ERG复合体进行了比较结构分析.
主要成果:
- 埃尔戈林,包括 lysergic 酸二甲基胺和埃尔戈他胺 (ERG),表现出强大的功能选择性,用于在5-HT2B受体的β-arrestin信号传递.
- 这些化合物在5-HT1B受体上显示了最小的偏差.
- 结构数据为偏向信号的分子基础提供了洞察力.
结论:
- 在5-HT2B受体上,ergoline诱导的偏差信号包括β-arrestin通路的优先激活.
- 5-HT2B和5-HT1B受体之间的结构差异导致了不同的信号结果.
- 这项研究增强了对GPCR结构-功能关系和偏见激进主义的理解.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

